Distal myasthenia gravis with a decrement, an increment, and denervation.

We present two patients with distal myasthenia gravis poorly responsive to immunomodulatory therapy. In addition to a typical decrement on slow repetitive nerve stimulation, both had borderline to low compound muscle action potential (CMAP) amplitudes, a large increment in CMAP amplitude and area after exercise, and active denervation in distal muscles. Both had elevated acetylcholine receptor antibody (AChR Ab) levels, but normal voltage-gated calcium channel antibody levels. We hypothesize that these electrophysiological findings represent a more severe form of myasthenia gravis.

[1]  P. O'Suilleabhain,et al.  Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. , 1995, The New England journal of medicine.

[2]  D. Sanders,et al.  Repetitive nerve stimulation studies in the Lambert–Eaton myasthenic syndrome , 1994, Muscle & nerve.

[3]  A. Vincent,et al.  Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[4]  N. Murray,et al.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases. , 1988, Brain : a journal of neurology.

[5]  J. Zengel,et al.  Stimulation‐induced factors which affect augmentation and potentiation of trasmitter release at the neuromuscular junction. , 1976, The Journal of physiology.

[6]  J. Desmedt,et al.  DIAGNOSIS OF MYASTHENIA GRAVIS BY NERVE STIMULATION * , 1976, Annals of the New York Academy of Sciences.

[7]  R. Young,et al.  THE RESULTS TO BE EXPECTED FROM ELECTRICAL TESTING IN THE DIAGNOSIS OF MYASTHENIA GRAVIS * , 1976, Annals of the New York Academy of Sciences.

[8]  R. J. Johns,et al.  Diagnostic difficulties encountered in the myasthenic syndrome sometimes associated with carcinoma , 1974, Journal of neurology, neurosurgery, and psychiatry.

[9]  Johnson Rj,et al.  Diagnostic difficulties encountered in the myasthenic syndrome sometimes associated with carcinoma , 1974 .

[10]  S. Oh.  The Eaton-Lambert syndrome in ocular myasthenia gravis. , 1974, Archives of neurology.

[11]  I. R. Williams,et al.  Incrementing responses in myasthenia gravis. , 1974, Archives of neurology.

[12]  E. Lambert,et al.  Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. , 1968, Mayo Clinic proceedings.

[13]  J. Motin,et al.  Essai du propanolol dans les troubles du rythme cardiaque d’intoxications expérimentales par le trichloréthylène , 1967 .

[14]  R. J. Johns,et al.  The nature of the defect in the Eaton‐Lambert syndrome , 1967, Neurology.

[15]  E. Lambert.  DEFECTS OF NEUROMUSCULAR TRANSMISSION IN SYNDROMES OTHER THAN MYASTHENIA GRAVIS , 1966, Annals of the New York Academy of Sciences.

[16]  A. M. Harvey.  Some preliminary observations on the clinical course of myasthenia gravis before and after thymectomy. , 1948, Bulletin of the New York Academy of Medicine.